Pfizer has agreed to settle over 10,000 lawsuits concerning the alleged connection between its product, Zantac, and cancer.
Tags: Pfizer
Pfizer's Plan to Bring Affordable Medicines to Low-Income Nations Slowed by Bureaucracy
Pfizer's goal to provide affordable medicines to 45 poor nations struggles with bureaucracy, reaching only 10 countries so far.
Kansas Sues Pfizer for Allegedly Hiding COVID Vaccine Risks, Misleading the Public
Kansas has filed a lawsuit against Pfizer, accusing the pharmaceutical giant of misleading the public about its COVID-19 vaccine.
Pfizer's Paxlovid Falls Short in Easing Long COVID-19 Symptoms: Stanford Study
Stanford University's study on Pfizer's antiviral Paxlovid finds no significant relief for long COVID-19 symptoms, prompting ongoing investigation into its potential effects on persistent symptoms in a groundbreaking clinical trial.
Pfizer Expects Lung Cancer Drug Lorbrena to Hit Over $1 Billion in Sales After Exceptional 5-Year Data
Pfizer has announced that its cancer drug, Lorbrena, is projected to generate over $1 billion in annual sales by 2030.
Latest News
Pfizer has agreed to settle over 10,000 lawsuits concerning its Zantac heartburn medication after it was found that a cancer risk was not disclosed.
A recent study conducted by the Centers for Disease Control and Prevention (CDC) has revealed that there is no link between COVID-19 vaccines and cardiac death in younger adults.
Pfizer is shifting its focus from COVID-related products to cancer drugs. Pfizer is shifting its focus on cancer drugs as the pharmaceutical giant tries to recover from a challenging period due to the decline of its COVID-19 business.
The cancer therapy was revealed during the Innovation Day event to engage investors and strengthen its position in cancer research and treatment.
Pfizer has agreed to pay $93 million to resolve antitrust claims by wholesale drug distributors accusing the pharmaceutical giant of conspiring with India's Ranbaxy Laboratories to delay the sales of cheaper versions of the cholesterol drug Lipitor.
Several major drug companies, including Pfizer, Sanofi, and Takeda Pharmaceutical, are gearing up to implement price hikes on over 500 drugs in the United States in early January.
Pharmaceutical giant Pfizer said it is set to finalize its $43 billion acquisition of cancer drugmaker Seagen this week.
The company called off the acquisition of Allergan after the U.S. Treasury issued the rule preventing the deal. Nevertheless, Chief Executive Officer Ian Read still has the investors support.
Pfizer and Allergan will have to scrap the merger deal following the new regulation from Treasury Department to stop the U.S. company moving overseas.
